🔴 Gyre Therapeutics is trading 6.35% down today as broader-market weakness may add pressure

Gyre Therapeutics is trading at $6.64, down 6.35%, with no clear company-specific announcement explaining the decline.

• The investor-relations page lists September 3, 2026, as the latest release.
• The Nasdaq Composite is down 1.73% in the provided market context, which may contribute to pressure on shares.
• The prior session’s rise was described as lacking a company-specific catalyst; the reason for this morning’s reversal remains unclear.